Oncodesign is partnering with Banook Central Imaging to offer validated image evaluation protocols and new cancer biomarkers to clinical researchers. "Our partnership with Banook Central Imaging will help us to provide our clients with practical solutions, ensuring that the measure of efficacy of anticancer therapies is attainable from one phase of development to the next," said Oncodesign founder and CEO Philippe Genne.

Related Summaries